Bacterial attachment to host cells is the initial step in the pathogenesis of infection. Our studies and those of others also showed that there is a significant correlation between the attachment of bacteria to human pharyngeal epithelial cells and the occurrence of respiratory tract infections. We identified the receptor on human pharyngeal epithelial cells which mediate binding of Moraxella catarrhalis and Haemophilus influenzae. In an attempt to prevent occurrence of infections, the effects of povidone-iodine gargling on the incidence of respiratory infections were investigated. The subjects included a total of 23 adult patients, both males and females, with chronic respiratory diseases showing repeated infections. Patients were asked to gargle more than 4 times/day with povidone-iodine gargle over extended periods of time, i.e. from several months up to over 2 years. The incidence of episodes of acute exacerbation of chronic respiratory infections decreased significantly when compared with that before use of povidone-iodine gargle. Episodes of infections with Pseudomonas aeruginosa, Staphylococcus aureus (including MRSA) and H. influenzae were reduced by about 50%. Results of this study suggest that povidone-iodine gargle is effective in providing a significant reduction in the incidence of acute exacerbations of chronic respiratory disease. We assume that the colonized bacteria were destroyed and thus infection could not occur. Therefore, povidone-iodine gargle may be used in these patients as a preventive therapy. Further studies are needed to find out the mechanism of action of this drug for the prevention of respiratory tract infections.

1.
Nagatake T: Therapy of chronic recurrent respiratory tract infections. J Jpn Thorac Dis 1989;27:289–292.
2.
Nagatake T: Lower respiratory tract infection related with bacerial adherence of upper respiratory tract in the aged. J Jpn Bronchoesophagol Soc 1991;42:144–149.
3.
Rikitomi N, Nagatake T, Sakamoto T, Matsumoto K: The role of MRSA (methicillin-resistant Staphylococcus aureus) adherence and colonization in the upper respiratory tract of geriatric patients in nosocomial pulmonary infections. Microbiol Immunol 1994;28:607–614.
4.
Rikitomi N, Ahmed K, Nagatake T: Moraxella(Branhamella) catarrhalis adherence to human bronchial and oropharyngeal cells: The role of adherence in lower respiratory tract infections. Microbiol Immunol 1997;41:487–494.
5.
Matsumoto K: Respiratory infections – Pathogenesis of acute and chronic infections. Kekkaku 1996;71:477–494.
6.
Rikitomi N, Mbaki N, Nagatake T, Matsumoto K: Adherence of Branhamella catarrhalis to human pharyngeal cells: Relationship between adherence in vitro and chronic respiratory infections. J Jpn Thorac Dis 1986;24:633–638.
7.
Mbaki N, Rikitomi N, Nagatake T, Matsumoto K: Correlation between Branhamella catarrhalis adherence to oropharyngeal cells and seasonal incidence of lower respiratory tract infections. Tohoku J Exp Med 1987;153:111–121.
8.
Masaki H, et al: Importance of a cleaning in upper airway by using povidone-iodine for the prevention of nosocomial pneumonia. J Jpn Assoc Infect Dis 2001;75:97–102.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.